The global pregabalin market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of the market can be attributed to factors such as increasing prevalence of chronic pain and rising geriatric population. Pregabalin is used for treating neuropathic pain, epilepsy, generalized anxiety disorder (GAD), and postherpetic neuralgia (PHN). It is also used for managing fibromyalgia syndrome (FMS) and restless leg syndrome (RLS).
The global pregabalin market has been segmented on the basis of type into 0.997%, 0.998%, and 0.999%. The tablet product segment accounted for the largest share in 2018 owing to its wide range of applications in various therapeutic areas such as epilepsy, neuropathic pain, GAD, PHN, FMS, RLS etc, which are driving its demand across geographies globally. The capsule product segment accounted for the second-largest share in 2018 due to its ease of administration with a lower risk profile than tablets or oral solutions; this factor is expected to drive its demand across geographies globally during the forecast period from 2021-2030.
North America dominated the global pregabalin market in 2018 due to high prevalence rates of chronic pain conditions such as arthritis and backache among adults aged 45 years or older; this factor will continue driving demand for pregabalin products during the forecast period from 2021-2030.
Pregabalin is a drug that is used to treat epilepsy, neuropathic pain, and generalized anxiety disorder. It is also used to treat fibromyalgia.
Industry Growth Insights published a new data on “Pregabalin Market”. The research report is titled “Pregabalin Market research by Types (0.997, 0.998, 0.999, Others), By Applications (Tablet Product, Capsule Product, Oral Solution Product), By Players/Companies ZCL Chemicals Ltd., Olon S.p.A., AASraw Biochemical Technology Co., Ltd., Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories Ltd., Angels Pharma India Pvt. Ltd., ARITE Pharmaceutical Co., Ltd., Bal Pharma Limited., Bazayan & Co., Aurobindo Pharma Ltd., Hikal Ltd., Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., CHEMO, Maps Laboratories Pvt. Ltd., Laurus Labs, Zhejiang Huahai Pharmaceutical Co., Ltd., Vasudha Pharma Chem Ltd., Sun Pharmaceutical Industries Ltd., CTX Life Sciences Pvt. Ltd., Srini Pharmaceuticals Pvt. Ltd.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pregabalin Market Research Report
By Type
0.997, 0.998, 0.999, Others
By Application
Tablet Product, Capsule Product, Oral Solution Product
By Companies
ZCL Chemicals Ltd., Olon S.p.A., AASraw Biochemical Technology Co., Ltd., Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories Ltd., Angels Pharma India Pvt. Ltd., ARITE Pharmaceutical Co., Ltd., Bal Pharma Limited., Bazayan & Co., Aurobindo Pharma Ltd., Hikal Ltd., Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., CHEMO, Maps Laboratories Pvt. Ltd., Laurus Labs, Zhejiang Huahai Pharmaceutical Co., Ltd., Vasudha Pharma Chem Ltd., Sun Pharmaceutical Industries Ltd., CTX Life Sciences Pvt. Ltd., Srini Pharmaceuticals Pvt. Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Pregabalin Market Report Segments:
The global Pregabalin market is segmented on the basis of:
Types
0.997, 0.998, 0.999, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet Product, Capsule Product, Oral Solution Product
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ZCL Chemicals Ltd.
- Olon S.p.A.
- AASraw Biochemical Technology Co., Ltd.
- Changzhou Pharmaceutical Factory (CPF)
- Almelo Pvt. Ltd.
- Divi’s Laboratories Ltd.
- Angels Pharma India Pvt. Ltd.
- ARITE Pharmaceutical Co., Ltd.
- Bal Pharma Limited.
- Bazayan & Co.
- Aurobindo Pharma Ltd.
- Hikal Ltd.
- Glenmark Life Sciences
- Dongbang FTL
- Teva Pharmaceutical Industries Ltd.
- Divi’s Laboratories Ltd.
- CHEMO
- Maps Laboratories Pvt. Ltd.
- Laurus Labs
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Vasudha Pharma Chem Ltd.
- Sun Pharmaceutical Industries Ltd.
- CTX Life Sciences Pvt. Ltd.
- Srini Pharmaceuticals Pvt. Ltd.
Highlights of The Pregabalin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.997
- 0.998
- 0.999
- Others
- By Application:
- Tablet Product
- Capsule Product
- Oral Solution Product
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pregabalin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pregabalin is a medication used to treat pain. It is also known as Lyrica.
Some of the key players operating in the pregabalin market are ZCL Chemicals Ltd., Olon S.p.A., AASraw Biochemical Technology Co., Ltd., Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi¢â‚¬â„¢s Laboratories Ltd., Angels Pharma India Pvt. Ltd., ARITE Pharmaceutical Co., Ltd., Bal Pharma Limited., Bazayan & Co., Aurobindo Pharma Ltd., Hikal Ltd., Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries Ltd., Divi¢â‚¬â„¢s Laboratories Ltd., CHEMO, Maps Laboratories Pvt. Ltd., Laurus Labs, Zhejiang Huahai Pharmaceutical Co., Ltd., Vasudha Pharma Chem Ltd., Sun Pharmaceutical Industries Ltd., CTX Life Sciences Pvt. Ltd., Srini Pharmaceuticals Pvt. Ltd..
The pregabalin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pregabalin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pregabalin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pregabalin Market - Supply Chain
4.5. Global Pregabalin Market Forecast
4.5.1. Pregabalin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pregabalin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pregabalin Market Absolute $ Opportunity
5. Global Pregabalin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pregabalin Market Size and Volume Forecast by Type
5.3.1. 0.997
5.3.2. 0.998
5.3.3. 0.999
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pregabalin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pregabalin Market Size and Volume Forecast by Application
6.3.1. Tablet Product
6.3.2. Capsule Product
6.3.3. Oral Solution Product
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pregabalin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pregabalin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pregabalin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pregabalin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pregabalin Demand Share Forecast, 2019-2026
9. North America Pregabalin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pregabalin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pregabalin Market Size and Volume Forecast by Application
9.4.1. Tablet Product
9.4.2. Capsule Product
9.4.3. Oral Solution Product
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pregabalin Market Size and Volume Forecast by Type
9.7.1. 0.997
9.7.2. 0.998
9.7.3. 0.999
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pregabalin Demand Share Forecast, 2019-2026
10. Latin America Pregabalin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pregabalin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pregabalin Market Size and Volume Forecast by Application
10.4.1. Tablet Product
10.4.2. Capsule Product
10.4.3. Oral Solution Product
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pregabalin Market Size and Volume Forecast by Type
10.7.1. 0.997
10.7.2. 0.998
10.7.3. 0.999
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pregabalin Demand Share Forecast, 2019-2026
11. Europe Pregabalin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pregabalin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pregabalin Market Size and Volume Forecast by Application
11.4.1. Tablet Product
11.4.2. Capsule Product
11.4.3. Oral Solution Product
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pregabalin Market Size and Volume Forecast by Type
11.7.1. 0.997
11.7.2. 0.998
11.7.3. 0.999
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pregabalin Demand Share, 2019-2026
12. Asia Pacific Pregabalin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pregabalin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pregabalin Market Size and Volume Forecast by Application
12.4.1. Tablet Product
12.4.2. Capsule Product
12.4.3. Oral Solution Product
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pregabalin Market Size and Volume Forecast by Type
12.7.1. 0.997
12.7.2. 0.998
12.7.3. 0.999
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pregabalin Demand Share, 2019-2026
13. Middle East & Africa Pregabalin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pregabalin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pregabalin Market Size and Volume Forecast by Application
13.4.1. Tablet Product
13.4.2. Capsule Product
13.4.3. Oral Solution Product
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pregabalin Market Size and Volume Forecast by Type
13.7.1. 0.997
13.7.2. 0.998
13.7.3. 0.999
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pregabalin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pregabalin Market: Market Share Analysis
14.2. Pregabalin Distributors and Customers
14.3. Pregabalin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ZCL Chemicals Ltd.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Olon S.p.A.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AASraw Biochemical Technology Co., Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Changzhou Pharmaceutical Factory (CPF)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Almelo Pvt. Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Divis Laboratories Ltd.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Angels Pharma India Pvt. Ltd.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ARITE Pharmaceutical Co., Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bal Pharma Limited.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bazayan & Co.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Aurobindo Pharma Ltd.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hikal Ltd.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Glenmark Life Sciences
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Dongbang FTL
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Teva Pharmaceutical Industries Ltd.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Divis Laboratories Ltd.
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. CHEMO
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Maps Laboratories Pvt. Ltd.
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Laurus Labs
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Zhejiang Huahai Pharmaceutical Co., Ltd.
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
